Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Asymptomatic Biochemical Relapse of Multiple Myeloma
NCT01087008Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Apr 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Apr 2010; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01087008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087008.